BCI and Adherence

Susan K. Boolbol, MD

Video Categories: PMO Interview with the Innovator Series: Volume 8

Dr Stephen C. Malamud and Dr Susan K. Boolbol discuss the importance of using a clinically validated test such as the Breast Cancer IndexSM (BCI) and its impact on patient confidence in their treatment plan.
November 10, 2012

PMO Interview with the Innovator Series: Volume 2

The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Peter Hirth, PhD, Chief Executive Officer of Plexxikon. In part one, Dr. Hirth discusses the use of biomarkers, segmenting the population of melanoma patients into subsets, and other aspects of personalized medicine.

December 3, 2013

Basal Cell Carcinoma Case Studies in Hedgehog Pathway Inhibition

In this final WCMC clinical commentary entitled, The Impact of Hedgehog Pathway Inhibitors on the Management of Patients with Basal Cell Carcinoma, Joel Claveau, MD, CSPQ, FRCPC; Dirk Schadendorf, MD; Nicole Basset-Seguin, MD, PhD and Aleksandar Sekulic, MD, PhD discuss how Hedgehog Pathway Inhibitors opened a new chapter of treatment [ Read More ]